You are here

HomeAbout UsTherapeutic Discovery Biology Advisory Board

Therapeutic Discovery Laboratories Biology Advisory Board

Cancer Research UK invests over £350 million in basic and translational cancer research per year, funding more than 4000 scientists, clinicians and healthcare professionals. The members of our Therapeutic Discovery Laboratories Biology Advisory Board have been selected to represent the best in CRUK basic and clinical research. They meet to critically review our biology skills, explore new ideas and assess alliance theme areas.

  • Gerard Evan

    Professor of Biochemistry and Head of Department, University of Cambridge

    Read more

  • Margaret C. Frame

    Professor of Cancer Research and Director of the MRC Institute of Genetics and Molecular Medicine

    Read more

  • Michelle D. Garrett

    Professor of Cancer Therapeutics and Faculty Director of Medical Sciences at the University of Kent

    Read more

  • Paul Moss

    Professor of Haematology at the University of Birmingham and Director of Research and Knowledge Transfer in the College of Medicine

    Read more

  • Peter Parker

    Senior Group Leader at the Francis Crick Institute and Director of the CRUK KHP Centre at King's College London

    Read more

  • Robert Bristow

    Professor of Cancer Studies and Director of the Manchester Cancer Research Centre

    Read more

  • Sarah Blagden

    Associate Professor of Experimental Cancer Therapeutics in the Department of Oncology, University of Oxford

    Read more

  • Simon Cook

    Babraham Institute Cambridge

    Read more